coversin
Peptideexperimental
The versine or versed sine is a trigonometric function found in some of the earliest trigonometric tables. The versine of an angle is 1 minus its cosine. — Wikipedia
Clinical trial activity
8 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
8
Phase 3
4
Phase 4
0
Earliest trial started Feb 1, 2016 (NCT02591862)
Timeline
Indications
Mechanism of action
- Complement C5INHIBITOR
C5 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaVersine ↗
Also known as
- coversin
- rva576
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05061771 | Phase 3 | Sep 30, 2021 | Akari Therapeutics |
| NCT04784455 | Phase 3 | Feb 1, 2021 | Akari Therapeutics |
| NCT04037891 | Phase 1/Phase 2 (Phase 2) | Feb 20, 2019 | Akari Therapeutics, University of London |
| NCT04035733 | Phase 2 | Sep 25, 2018 | Akari Therapeutics |
| NCT03588026 | Phase 3 | Jun 20, 2018 | Akari Therapeutics, Vilnius University |
| NCT03427060 | Phase 2 | May 14, 2018 | Akari Therapeutics |
| NCT03829449 | Phase 3 | Mar 13, 2017 | Akari Therapeutics |
| NCT02591862 | Phase 2 | Feb 1, 2016 | Akari Therapeutics, Radboud University |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Akari Therapeutics | For profit | 8 | 8 | 2 | 2016 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Vilnius University | Academic/Hospital | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1